What is a Kayexalate enema, and what is it used for?
Kayexalate is the brand name for sodium polystyrene sulfonate (SPS), a medication used to bind potassium in the gut so the body can remove it. A “Kayexalate enema” is the same medication given rectally (as an enema) rather than by mouth, typically to treat hyperkalemia (high blood potassium) when clinicians want a non-oral route.
How does a Kayexalate enema work?
Sodium polystyrene sulfonate exchanges sodium for potassium in the gastrointestinal tract. By binding potassium, it reduces the amount of free potassium available for absorption, which lowers serum potassium levels over time.
Is Kayexalate given by mouth or rectally—when would an enema be used?
Oral SPS is commonly used, but a rectal route may be considered when:
- the patient cannot take medications by mouth, or
- clinicians prefer/need an alternative administration route.
The choice depends on the clinical setting, urgency, and patient factors.
How fast does it lower potassium?
SPS generally does not lower potassium instantly. The onset is slower than dialysis, and clinicians monitor potassium levels and the patient’s ECG/clinical status closely, especially in severe hyperkalemia.
What are the risks and side effects of Kayexalate enemas?
Rectal administration has been associated with serious gastrointestinal injury in some reports, including bowel necrosis. Patients are monitored for abdominal pain, distension, bleeding, or signs of serious GI complications, particularly in higher-risk groups (for example, patients with bowel disease, recent surgery, or significant constipation).
Common, less severe side effects can include constipation, nausea, or GI irritation, depending on the formulation and route.
Are there alternatives to a Kayexalate enema?
Common alternatives used for hyperkalemia include:
- dialysis for urgent, life-threatening hyperkalemia
- other potassium binders (depending on country guidelines and patient context)
Clinicians choose among options based on severity, speed needed, kidney function, and risk of GI adverse effects.
What should patients ask their clinician before receiving a Kayexalate enema?
Patients (or caregivers) typically ask:
- Why the enema route is being used instead of oral treatment
- How often potassium will be rechecked
- What symptoms would signal a serious complication (for example, worsening abdominal pain, vomiting, or blood in stool)
- Whether the patient has any GI risk factors that change the risk-benefit balance
Sources
No sources were provided in your prompt, and none are required to answer the general “Kayexalate enema” definition and use. If you want, tell me your country/clinical context (urgent hyperkalemia in hospital vs outpatient; adult vs child), and I can tailor the information to typical practice.